BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

PURPOSE: Metastatic melanoma, a highly vascularized tumor with strong expression of vascular endothelial growth factor, has an overall poor prognosis. We conducted a placebo-controlled, double-blind phase II study of carboplatin plus paclitaxel with or without bevacizumab in patients with previously...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Kim, Kevin B., Sosman, Jeffrey A., Fruehauf, John P., Linette, Gerald P., Markovic, Svetomir N., McDermott, David F., Weber, Jeffrey S., Nguyen, Hoa, Cheverton, Peter, Chen, Daniel, Peterson, Amy C., Carson, William E., O'Day, Steven J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669379/
https://ncbi.nlm.nih.gov/pubmed/22124101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.34.6270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados